Optimark and Nodule - a phase IV clinical study of FDA data
Summary:
Nodule is reported as a side effect among people who take Optimark (gadoversetamide), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Omniscan, and have High blood cholesterol.
The phase IV clinical study analyzes which people have Nodule when taking Optimark. It is created by eHealthMe based on reports of 3,054 people who have side effects when taking Optimark from the FDA, and is updated regularly.
What is Optimark?
Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.
What is Nodule?
Nodule (a growth of abnormal tissue) is found to be associated with 1,025 drugs and 876 conditions by eHealthMe. Check the latest studies of Nodule.
3,054 people reported to have side effects when taking Optimark.
Among them, 13 people (0.43%) have Nodule.
Among these 13 people:
How long have people been on Optimark when they have Nodule? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Nodule when taking Optimark? *
- female: 38.46 %
- male: 61.54 %
What is the age of people who have Nodule when taking Optimark? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 15.38 %
- 40-49: 38.46 %
- 50-59: 23.08 %
- 60+: 23.08 %
What are other drugs people take besides Optimark? *
- Omniscan: 10 people, 76.92%
- Magnevist: 7 people, 53.85%
- Diovan: 6 people, 46.15%
- Multihance: 6 people, 46.15%
- Calcitriol: 6 people, 46.15%
- Prohance: 6 people, 46.15%
- Renagel: 6 people, 46.15%
- Paxil: 4 people, 30.77%
- Zocor: 4 people, 30.77%
- Minoxidil: 4 people, 30.77%
What are other side effects people have besides Nodule? *
- Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 13 people, 100.00%
- Weakness: 9 people, 69.23%
- Rashes (redness): 8 people, 61.54%
- Gait Disturbance: 7 people, 53.85%
- Skin Induration (an abnormally hard spot or area on the skin): 6 people, 46.15%
- Oedema Peripheral (superficial swelling): 6 people, 46.15%
- Itching: 6 people, 46.15%
- Pain In Extremity: 6 people, 46.15%
- Fall: 6 people, 46.15%
- Hypoaesthesia (reduced sense of touch or sensation): 6 people, 46.15%
What are the existing conditions these people have? *
- Nuclear Magnetic Resonance Imaging Brain: 4 people, 30.77%
- High Blood Cholesterol: 4 people, 30.77%
- Bipolar Disorder (mood disorder): 3 people, 23.08%
- Pain: 2 people, 15.38%
- Anaemia (lack of blood): 2 people, 15.38%
- Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 1 person, 7.69%
- Depression: 1 person, 7.69%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Optimark and have Nodule?
- Check whether Nodule is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Optimark:
- Optimark (3,055 reports)
Nodule treatments and more:
- Nodule (15,836 reports)
How severe was Nodule and when was it recovered:
Expand to all the drugs that have ingredients of gadoversetamide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Optimark:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Nodule:
- Nodule (1,025 drugs)
Browse all the conditions that are associated with Nodule:
- Nodule (876 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gadoversetamide (the active ingredients of Optimark) and Optimark (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
No recent updates.